Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteinsLeah Hernandez, Thomas Ebert, Agnė Laučytė-Cibulskienė et al.|Scientific Reports|2022Cited by 64
Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortalityAgnė Laučytė-Cibulskienė, Karolina Kublickiene, Liam J. Ward et al.|Biology of Sex Differences|2021Cited by 30